<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang Y</submitter><funding>UKRI | Biotechnology and Biological Sciences Research Council</funding><funding>Biotechnology and Biological Sciences Research Council</funding><pagination>e0202721</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8941929</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>96(6)</volume><pubmed_abstract>Marek's disease virus (MDV) is a member of the genus Mardivirus in the subfamily &lt;i>Alphaherpesvirinae&lt;/i>. There are three different serotypes of MDV designated as MDV-1 (&lt;i>Gallid herpesvirus&lt;/i> type 2), MDV-2 (&lt;i>Gallid herpesvirus&lt;/i> type 3), and MDV-3 (Meleagrid herpesvirus 1, herpesvirus of turkeys, HVT). MDV-1 is the only serotype that induces Marek's disease (MD), a lymphoproliferative disorder resulting in aggressive T-cell lymphomas and paralytic symptoms. In the lymphomas and lymphoblastoid cell lines (LCL) derived from them, MDV establishes latent infection with limited viral gene expression. The latent viral genome in LCL can be activated by co-cultivation with chicken embryo fibroblast (CEF) monolayers. MSB-1, one of the first MDV-transformed LCL established from the spleni</pubmed_abstract><journal>Journal of virology</journal><pubmed_title>Targeted Deletion of Glycoprotein B Gene by CRISPR/Cas9 Nuclease Inhibits &lt;i>Gallid herpesvirus&lt;/i> Type 3 in Dually Infected Marek's Disease Virus-Transformed Lymphoblastoid Cell Line MSB-1.</pubmed_title><pmcid>PMC8941929</pmcid><funding_grant_id>BBS/OS/NW/000007</funding_grant_id><funding_grant_id>BB/R007896/1</funding_grant_id><funding_grant_id>BBS/E/I/00007039</funding_grant_id><funding_grant_id>BBS/E/I/00007032</funding_grant_id><funding_grant_id>BB/R007632/1</funding_grant_id><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Nair V</pubmed_authors><pubmed_authors>Yao Y</pubmed_authors><pubmed_authors>Tang N</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Moffat K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeted Deletion of Glycoprotein B Gene by CRISPR/Cas9 Nuclease Inhibits &lt;i>Gallid herpesvirus&lt;/i> Type 3 in Dually Infected Marek's Disease Virus-Transformed Lymphoblastoid Cell Line MSB-1.</name><description>Marek's disease virus (MDV) is a member of the genus Mardivirus in the subfamily &lt;i>Alphaherpesvirinae&lt;/i>. There are three different serotypes of MDV designated as MDV-1 (&lt;i>Gallid herpesvirus&lt;/i> type 2), MDV-2 (&lt;i>Gallid herpesvirus&lt;/i> type 3), and MDV-3 (Meleagrid herpesvirus 1, herpesvirus of turkeys, HVT). MDV-1 is the only serotype that induces Marek's disease (MD), a lymphoproliferative disorder resulting in aggressive T-cell lymphomas and paralytic symptoms. In the lymphomas and lymphoblastoid cell lines (LCL) derived from them, MDV establishes latent infection with limited viral gene expression. The latent viral genome in LCL can be activated by co-cultivation with chicken embryo fibroblast (CEF) monolayers. MSB-1, one of the first MDV-transformed LCL established from the spleni</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-04T07:55:08.05Z</modification><creation>2025-04-04T07:55:08.05Z</creation></dates><accession>S-EPMC8941929</accession><cross_references><pubmed>35107377</pubmed><doi>10.1128/jvi.02027-21</doi></cross_references></HashMap>